Netherlands· NL-d80c10ed2133

Saxagliptine Sandoz 5 mg, filmomhulde tabletten

A saxagliptin product containing saxagliptinehydrochloride, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC A10BH03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about saxagliptinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Saxagliptin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BH03 (saxagliptin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search saxagliptin products by name

Saxagliptin · ATC A10BH03

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of saxagliptin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.31 in France to $3.59 in Italy — a ×12 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Saxagliptin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

IT Italy$3.59
CH Switzerland$3.41
FR France$0.31

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SAXAGLIPTINEHYDROCHLORIDE
Manufacturer: Sandoz B.V.
Country: Netherlands (NL)
ATC code: A10BH03
ATC class: Saxagliptin
Defined daily dose: 5 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
123113

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

449 interactions on record for saxagliptin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check saxagliptin against other medicines How interaction checks work

Saxagliptin · interactions on record

449 records

3 severe
404 moderate
42 minor

Most severe, free to view

ClotrimazoleA01AB18moderate
CimetidineA02BA01moderate
SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Saxagliptin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All saxagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

France · Saxagliptine Arrow, Saxagliptine Biogaran
United Kingdom (Northern Ireland) · Saxagliptin Sandoz, Saxagliptin Zydus Pharmaceuticals Uk
Hungary · Saxagliptin Pharos
Iceland · Onglyza
Liechtenstein · Onglyza
Malta · Saxagliptin Pharos
Norway · Onglyza
Portugal · Saxagliptina Generis, Saxagliptina Generis Phar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/33440d89-9947-44c0-8f55-c3931ccb6c81
GET /v1/drugs/33440d89-9947-44c0-8f55-c3931ccb6c81?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123113_smpc_en.pdf",
  "strength": null,
  "atc_label": "Saxagliptin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123113",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "SAXAGLIPTINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123113_piluk.pdf",
  "authorised_at": "2019/06/06",
  "procedure_number": "NL/H/4425/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "123113",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about saxagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console